blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2089531

EP2089531 - BIOSENSOR SYSTEM HAVING ENHANCED STABILITY AND HEMATOCRIT PERFORMANCE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  07.06.2019
FormerGrant of patent is intended
Status updated on  04.02.2019
FormerExamination is in progress
Status updated on  29.11.2016
Most recent event   Tooltip23.07.2021Lapse of the patent in a contracting state
New state(s): MT		published on 25.08.2021  [2021/34]
Applicant(s)For all designated states
Ascensia Diabetes Care Holdings AG
Peter-Merian Strasse 90
4052 Basel / CH
[2016/33]
Former [2013/49]For all designated states
Bayer HealthCare LLC
100 Bayer Boulevard
Whippany, NJ 07981-0915 / US
Former [2009/34]For all designated states
Bayer HealthCare, LLC
555 White Plains Road
Tarrytown, NY 10591 / US
Inventor(s)01 / WU, Huan-Ping
14374 Shoreline Dr.
Granger, IN 46530 / US
02 / NELSON, Christine, D.
68972 Lake Street
Edwardsburg, Michigan 49112 / US
03 / SPRADLIN, Hope
10232 Ashley's Meadow Dr.
Granger, Indiana 46530 / US
04 / MAURER, Eric
5633 Osage Lake Dr.
Apt. 3B
Mishawaka, Indiana 46545 / US
 [2019/28]
Former [2009/34]01 / WU, Huan-Ping
14374 Shoreline Dr.
Granger, IN 46530 / US
02 / NELSON, Christine, D.
68972 Lake Street
Edwardsburg, Michigan 49112 / US
03 / SPRADLIN, Hope
10232 Ashley's Meadow Dr.
Grainger, Indiana 46530 / US
04 / MAURER, Eric
5633 Osage Lake Dr. Apt. 3B
Mishawaka, Indiana 46545 / US
Representative(s)Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Postfach 18 04 09
40571 Düsseldorf / DE
[N/P]
Former [2019/28]Gille Hrabal
Postfach 18 04 09
40571 Düsseldorf / DE
Former [2013/22]BIP Patents
Bayer Intellectual Property GmbH
IPO-P-MON
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Former [2009/34]Linhart, Angela
Bayer HealthCare AG Law and Patents, Patents and Licensing Building Q18
51368 Leverkusen / DE
Application number, filing date07814768.309.09.2007
[2009/34]
WO2007US77955
Priority number, dateUS20060846688P22.09.2006         Original published format: US 846688 P
[2009/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008036516
Date:27.03.2008
Language:EN
[2008/13]
Type: A1 Application with search report 
No.:EP2089531
Date:19.08.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 27.03.2008 takes the place of the publication of the European patent application.
[2009/34]
Type: B1 Patent specification 
No.:EP2089531
Date:10.07.2019
Language:EN
[2019/28]
Search report(s)International search report - published on:EP27.03.2008
ClassificationIPC:G01N27/327, G01N33/49, C12Q1/00, G01N33/543
[2019/01]
CPC:
G01N27/3272 (EP,US); G01N27/3274 (US); C12Q1/004 (EP,US);
C12Q1/006 (EP,US); G01N27/327 (EP,US); G01N27/3273 (US);
G01N33/49 (EP); G01N33/5438 (US); Y10S435/817 (EP,US) (-)
Former IPC [2009/34]C12Q1/00, G01N27/30, G01N33/487
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/28]
Former [2009/34]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:BIOSENSORSYSTEM MIT VERBESSERTER STABILITÄT UND HÄMATOKRIT-AUSFÜHRUNG[2009/34]
English:BIOSENSOR SYSTEM HAVING ENHANCED STABILITY AND HEMATOCRIT PERFORMANCE[2009/34]
French:SYSTÈME DE BIOCAPTEUR PRÉSENTANT UNE STABILITÉ AMÉLIORÉE ET UNE FONCTION DE MESURE D'HÉMATOCRITE[2009/34]
Entry into regional phase22.04.2009National basic fee paid 
22.04.2009Designation fee(s) paid 
22.04.2009Examination fee paid 
Examination procedure01.04.2009Amendment by applicant (claims and/or description)
22.04.2009Examination requested  [2009/34]
18.10.2012Despatch of a communication from the examining division (Time limit: M06)
09.04.2013Reply to a communication from the examining division
27.07.2016Despatch of a communication from the examining division (Time limit: M04)
29.11.2016Reply to a communication from the examining division
16.11.2018Cancellation of oral proceeding that was planned for 21.11.2018
21.11.2018Date of oral proceedings (cancelled)
05.02.2019Communication of intention to grant the patent
27.05.2019Fee for grant paid
27.05.2019Fee for publishing/printing paid
27.05.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19173431.8  / EP3543348
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.10.2012
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
25.09.2009Renewal fee patent year 03
27.09.2010Renewal fee patent year 04
26.09.2011Renewal fee patent year 05
25.09.2012Renewal fee patent year 06
27.09.2013Renewal fee patent year 07
29.09.2014Renewal fee patent year 08
28.09.2015Renewal fee patent year 09
27.09.2016Renewal fee patent year 10
27.09.2017Renewal fee patent year 11
27.09.2018Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.09.2007
AT10.07.2019
CY10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
MT10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SI10.07.2019
SK10.07.2019
TR10.07.2019
IE09.09.2019
LU09.09.2019
BE30.09.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
[2021/34]
Former [2021/32]HU09.09.2007
AT10.07.2019
CY10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SI10.07.2019
SK10.07.2019
TR10.07.2019
IE09.09.2019
LU09.09.2019
BE30.09.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2021/26]AT10.07.2019
CY10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SI10.07.2019
SK10.07.2019
TR10.07.2019
IE09.09.2019
LU09.09.2019
BE30.09.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/37]AT10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SI10.07.2019
SK10.07.2019
TR10.07.2019
IE09.09.2019
LU09.09.2019
BE30.09.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/36]AT10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SK10.07.2019
TR10.07.2019
IE09.09.2019
LU09.09.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/35]AT10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SK10.07.2019
TR10.07.2019
LU09.09.2019
BG10.10.2019
GR11.10.2019
PT11.11.2019
IS24.02.2020
Former [2020/25]AT10.07.2019
CZ10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
SK10.07.2019
TR10.07.2019
BG10.10.2019
GR11.10.2019
PT11.11.2019
IS24.02.2020
Former [2020/24]AT10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
MC10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
TR10.07.2019
BG10.10.2019
GR11.10.2019
PT11.11.2019
IS24.02.2020
Former [2020/23]AT10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
NL10.07.2019
PL10.07.2019
RO10.07.2019
SE10.07.2019
TR10.07.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/22]AT10.07.2019
DK10.07.2019
EE10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
NL10.07.2019
SE10.07.2019
TR10.07.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/17]AT10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
NL10.07.2019
SE10.07.2019
TR10.07.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/12]AT10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
NL10.07.2019
SE10.07.2019
BG10.10.2019
GR11.10.2019
IS10.11.2019
PT11.11.2019
Former [2020/11]AT10.07.2019
FI10.07.2019
LT10.07.2019
LV10.07.2019
NL10.07.2019
SE10.07.2019
BG10.10.2019
GR11.10.2019
PT11.11.2019
Former [2020/10]AT10.07.2019
FI10.07.2019
LT10.07.2019
NL10.07.2019
SE10.07.2019
BG10.10.2019
PT11.11.2019
Former [2020/09]FI10.07.2019
LT10.07.2019
NL10.07.2019
Former [2020/08]LT10.07.2019
NL10.07.2019
Former [2020/07]NL10.07.2019
Cited inInternational search[XY]EP1074832  (BAYER AG [US]) [X] 1-16,20-25 * column 3, line 49 - line 53; figure 3 * [Y] 17-19;
 [YX]WO2006042304  (BAYER HEALTHCARE LLC [US], et al) [Y] 17-19 * paragraph [0129] - paragraph [0132] * [X] 26-43,47-50;
 [A]WO2006096619  (BAYER HEALTHCARE LLC [US], et al) [A] 1-50 * the whole document *;
 [X]US6413398  (GERHARDT GEOFF CHARLES [US], et al) [X] 26-40,43,47-50 * column 5, line 14 - line 52; figure 3 *
ExaminationUS6120676
 US2005016844
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.